Philip J. Monroe

836 total citations
23 papers, 656 citations indexed

About

Philip J. Monroe is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Philip J. Monroe has authored 23 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 15 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Philip J. Monroe's work include Pain Mechanisms and Treatments (14 papers), Neuropeptides and Animal Physiology (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). Philip J. Monroe is often cited by papers focused on Pain Mechanisms and Treatments (14 papers), Neuropeptides and Animal Physiology (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). Philip J. Monroe collaborates with scholars based in United States, Netherlands and Canada. Philip J. Monroe's co-authors include David J. Smith, Terriann Crisp, David J. Smith, David J. Smith, Deborah L. Smith, Mark O. Urban, Jeffrey Smith, Charles R. Craig, Danielle Gully and Georgina M. Lambert and has published in prestigious journals such as Brain Research, Pain and Annals of the New York Academy of Sciences.

In The Last Decade

Philip J. Monroe

22 papers receiving 634 citations

Peers

Philip J. Monroe
Julie Wieseler United States
TL Yaksh United States
Alberto Sánchez Spain
Jean-Sébastien Austin Canada
Cherkaouia Kibaly United States
Chihiro Kaneko Japan
Erika L. Galer United States
Judit Gál Hungary
Doris Gruber-Schoffnegger Austria
Wenhua Han Japan
Julie Wieseler United States
Philip J. Monroe
Citations per year, relative to Philip J. Monroe Philip J. Monroe (= 1×) peers Julie Wieseler

Countries citing papers authored by Philip J. Monroe

Since Specialization
Citations

This map shows the geographic impact of Philip J. Monroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Monroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Monroe more than expected).

Fields of papers citing papers by Philip J. Monroe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Monroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Monroe. The network helps show where Philip J. Monroe may publish in the future.

Co-authorship network of co-authors of Philip J. Monroe

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Monroe. A scholar is included among the top collaborators of Philip J. Monroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Monroe. Philip J. Monroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monroe, Philip J., et al.. (2011). Characterization of a functional observational battery in rodents and non human primates. Journal of Pharmacological and Toxicological Methods. 64(1). e20–e20.
2.
Mariotti, Angelo & Philip J. Monroe. (1998). PHARMACOLOGIC MANAGEMENT OF PERIODONTAL DISEASES USING SYSTEMICALLY ADMINISTERED AGENTS. Dental Clinics of North America. 42(2). 245–262. 14 indexed citations
3.
Smith, David J., Philip J. Monroe, Danielle Gully, et al.. (1997). Dose-Dependent Pain-Facilitatory and -Inhibitory Actions of Neurotensin Are Revealed by SR 48692, a Nonpeptide Neurotensin Antagonist: Influence on the Antinociceptive Effect of Morphine,. Journal of Pharmacology and Experimental Therapeutics. 282(2). 899–908. 60 indexed citations
4.
5.
Monroe, Philip J., et al.. (1996). Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 65–73. 29 indexed citations
6.
Monroe, Philip J., et al.. (1995). Opioid effects on spinal [3H]5-hydroxytryptamine release are not related to their antinociceptive action. European Journal of Pharmacology. 272(1). 51–56. 6 indexed citations
7.
Monroe, Philip J., et al.. (1995). Spinal Imidazoline Receptors Do Not Mediate the Antinociceptive Action of Intrathecal Clonidine in the Rat. Annals of the New York Academy of Sciences. 763(1). 497–500. 6 indexed citations
8.
Smith, David J., Deborah L. Smith, Philip J. Monroe, Mark O. Urban, & Danielle Gully. (1995). A NON-PEPTIDE NEUROTENSIN ANTAGONIST (SR48692) POTENTIATES THE ANTINOCICEPTIVE ACTION OF MORPHINE IN RATS. 1(4). 750–753. 2 indexed citations
9.
Monroe, Philip J., et al.. (1995). Spinal nonadrenergic imidazoline receptors do not mediate the antinociceptive action of intrathecal clonidine in the rat.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1057–1062. 24 indexed citations
10.
Smith, David J., et al.. (1994). Multiple opioid receptors mediate descending pain modulation from the periaqueductal gray (PAG). Regulatory Peptides. 53. S99–S100. 1 indexed citations
11.
12.
Blier, Pierre, Philip J. Monroe, Claude Bouchard, Deborah L. Smith, & David J. Smith. (1993). 5‐HT3 receptors which modulate [3H]5‐HT release in the guinea pig hypothalamus are not autoreceptors. Synapse. 15(2). 143–148. 20 indexed citations
13.
14.
Monroe, Philip J., et al.. (1992). Opioid receptors mediating antinociception from β-endorphin and morphine in the periaqueductal gray. Neuropharmacology. 31(11). 1137–1150. 31 indexed citations
15.
Garlick, Russell, et al.. (1991). Complement C5a Receptor Assay for High Throughput Screening. Journal of Receptor Research. 11(1-4). 115–128. 3 indexed citations
16.
Monroe, Philip J., et al.. (1991). Evaluation of the interactions of serotonergic and adrenergic drugs with μ, δ, and κ opioid binding sites. Neuroscience Letters. 133(2). 229–232. 11 indexed citations
17.
Monroe, Philip J., et al.. (1987). Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology. 26(9). 1253–1260. 148 indexed citations
18.
Nelson, D. L., Philip J. Monroe, Georgina M. Lambert, & Henry I. Yamamura. (1987). [3H]Spiroxatrine labels a serotonin1A-like site in the rat hippocampus. Life Sciences. 41(13). 1567–1576. 28 indexed citations
19.
Smith, David J., et al.. (1985). Ketamine analgesia is not related to an opiate action in the periaqueductal gray region of the rat brain. Pain. 21(3). 253–265. 40 indexed citations
20.
Monroe, Philip J. & David J. Smith. (1985). Demonstration of an Autoreceptor Modulating the Release of [3H]5‐Hydroxytryptamine from a Synaptosomal‐Rich Spinal Cord Tissue Preparation. Journal of Neurochemistry. 45(6). 1886–1894. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Wieseler Breakdown of academic impact, for papers by TL Yaksh Breakdown of academic impact, for papers by Alberto Sánchez Breakdown of academic impact, for papers by Jean-Sébastien Austin Breakdown of academic impact, for papers by Cherkaouia Kibaly Breakdown of academic impact, for papers by Chihiro Kaneko Breakdown of academic impact, for papers by Erika L. Galer Breakdown of academic impact, for papers by Judit Gál Breakdown of academic impact, for papers by Doris Gruber-Schoffnegger Breakdown of academic impact, for papers by Wenhua Han
Rankless by CCL
2026